Your browser doesn't support javascript.
loading
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy.
Lahdensuo, Kanerva; Erickson, Andrew; Saarinen, Irena; Seikkula, Heikki; Lundin, Johan; Lundin, Mikael; Nordling, Stig; Bützow, Anna; Vasarainen, Hanna; Boström, Peter J; Taimen, Pekka; Rannikko, Antti; Mirtti, Tuomas.
Afiliação
  • Lahdensuo K; Department of Urology, Meilahti Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Erickson A; Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland.
  • Saarinen I; Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland.
  • Seikkula H; Department of Urology, University of Turku and Turku University Hospital, Turku, Finland.
  • Lundin J; Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland.
  • Lundin M; Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland.
  • Nordling S; Department of Pathology, HUSLAB and Medicum, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Bützow A; United Medix Laboratories, Pathology, Helsinki, Finland.
  • Vasarainen H; Department of Urology, Meilahti Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Boström PJ; Department of Urology, University of Turku and Turku University Hospital, Turku, Finland.
  • Taimen P; Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland.
  • Rannikko A; Department of Urology, Meilahti Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Mirtti T; Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland.
Mod Pathol ; 29(12): 1565-1574, 2016 12.
Article em En | MEDLINE | ID: mdl-27562498
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / PTEN Fosfo-Hidrolase Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / PTEN Fosfo-Hidrolase Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Finlândia